About BioGene
BioGene is a company based in Peterborough (United Kingdom) founded in 1993.. BioGene offers products and services including CENOS and SoftGenetics Solutions. BioGene operates in a competitive market with competitors including ArcherDX, Qiagen, Devyser, Third Wave Technologies and DxTerity, among others.
- Headquarter Peterborough, United Kingdom
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Biogene Limited
- Date of Incorporation 17 Mar, 1993
- Jurisdiction HARVARD WAY KIMBOLTON, CAMBRIDGESHIRE
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Latest Funding Round
$700 K (USD), Post-IPO
Dec 29, 2009
- Investors
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of BioGene
BioGene offers a comprehensive portfolio of products and services, including CENOS and SoftGenetics Solutions. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Portable system for rapid RT-qPCR testing from crude samples worldwide.
Tools for genetic analysis in diagnostic applications.
Funding Insights of BioGene
- Total Funding Total Funding
- Total Rounds 2
- Last Round Post-IPO — $700,000
-
First Round
First Round
(08 Feb 2007)
- Investors Count 1
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Dec, 2009 | Amount | Post-IPO - BioGene | Valuation |
investors |
|
| Feb, 2007 | Amount | Grant - BioGene | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in BioGene
BioGene has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include National Research Council Canada. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Scientific and technological research is conducted for Canada's benefit.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by BioGene
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - BioGene
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Biogene Comparisons
Competitors of BioGene
BioGene operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as ArcherDX, Qiagen, Devyser, Third Wave Technologies and DxTerity, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Molecular cancer diagnostic products are developed using patented AMP technology.
|
|
| domain | founded_year | HQ Location |
Products and reagents for molecular diagnostic assays are supplied.
|
|
| domain | founded_year | HQ Location |
Provider of molecular diagnostic kits for cancer, hereditary diseases, and reproductive disorders
|
|
| domain | founded_year | HQ Location |
Molecular diagnostic devices and reagents are developed and marketed.
|
|
| domain | founded_year | HQ Location |
Provider of a direct-to-consumer, non-clinical genetic tests
|
|
| domain | founded_year | HQ Location |
Molecular diagnostic kits for infectious diseases are developed and manufactured.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Biogene
Frequently Asked Questions about BioGene
When was BioGene founded?
BioGene was founded in 1993 and raised its 1st funding round 14 years after it was founded.
Where is BioGene located?
BioGene is headquartered in Peterborough, United Kingdom.
What does BioGene do?
BioGene is a molecular biology company based in Cambridge UK that manufactures reagents and instruments for assay design and development, DNARNA purification, amplification and analysis. As of September 2016, the company is also in the process of developing specialized instruments for direct PCR amplification from crude samples, and for POC detection of sepsis called QuRapID and QuType, respectively. Both the instruments are based on the companys proprietary UltraRapid PCR system that consists of a single tube DNA extraction and PCR process and associated reagents and instrumentation. QuRapID is designed for rapid identification of bacteria directly from primary samples using a multiplexed RT-PCR approach. QuType is in development as a POC device for simple and rapid diagnosis of sepsis in patients using the UltraRapid PCR platform.
Who are the top competitors of BioGene?
What products or services does BioGene offer?
BioGene offers CENOS and SoftGenetics Solutions.
Who are BioGene's investors?
BioGene has 1 investor. Key investors include National Research Council Canada.